SanBio

SanBio was established in the world's mecca for biopharmaceutical development, the San Francisco Bay Area (Silicon Valley), in 2001. Since its establishment, SanBio has worked to develop new neuro-regenerative cell medicines to serve the world market.SanBio?s goal is to become a global leader in the field of next-generation regenerative cell medicine. Based upon our strength of our research and development in the U.S. and the fast-track approval system in Japan, we expect to become a global leader in regenerative cell medicines and generate robust growth as a company. We look forward to your continued guidance and encouragement. Mission:?SanBio Develops Regenerative Medicines, Creating Benefits for Patients and Value for Stakeholders.